Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Multiple sclerosis (MS) is primarily recognised as a chronic demyelinating disease of the central nervous system, yet its impact extends to the autonomic nervous system (ANS), which governs vital ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

May 30, 2025, is the 17 th annual World Multiple Sclerosis Day, a day when the global medical community focuses on those living with Multiple Sclerosis (MS), a complex and frequently misunderstood ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

We know so much more about multiple sclerosis (MS) than we used to. But one important theme is that we’ve become much better at treating the relapsing form of this disease and changing its natural ...

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.